Explore

@esicm.bsky.social

#NewRelease๐ŸŽ™๏ธ Tune in to our latest podcast - ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ ๐—˜๐—ฆ๐—œ๐—–๐—  ๐—ด๐˜‚๐—ถ๐—ฑ๐—ฒ๐—น๐—ถ๐—ป๐—ฒ๐˜€ ๐—ผ๐—ป ๐—ฐ๐—ถ๐—ฟ๐—ฐ๐˜‚๐—น๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐˜€๐—ต๐—ผ๐—ฐ๐—ธ ๐—ฎ๐—ป๐—ฑ ๐—ต๐—ฒ๐—บ๐—ผ๐—ฑ๐˜†๐—ป๐—ฎ๐—บ๐—ถ๐—ฐ ๐—บ๐—ผ๐—ป๐—ถ๐˜๐—ผ๐—ฟ๐—ถ๐—ป๐—ด

#ESICMTalk 10 ๐Ÿ‘‰ www.esicm.org/esicm-talk-2...

๐Ÿ’กExplore

#ESICM

@esicm.bsky.social

#NewRelease๐ŸŽ™๏ธ Tune in to our latest podcast - ๐——๐—ฟ๐˜‚๐—ด ๐—ฐ๐—น๐—ฒ๐—ฎ๐—ฟ๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ถ๐—ป ๐—ฅ๐—ฅ๐—ง: ๐—ช๐—ต๐—ฎ๐˜ ๐—ฎ๐—ฟ๐—ฒ ๐˜๐—ต๐—ฒ ๐—ฑ๐—ฒ๐˜๐—ฒ๐—ฟ๐—บ๐—ถ๐—ป๐—ฎ๐—ป๐˜๐˜€?

#ESICMTalk 9 ๐Ÿ‘‰ www.esicm.org/esicm-talk-d...

๐Ÿ’กExplore how drug characteristics, patient factors, and #CRRT circuit variables interact to influence drug clearance & why personalised dosing matters

#ESICM